Evidence map›Paper›PMID 28807217›Full record

ArticleThe Journal of surgical research2017

Adenosine triphosphate as a molecular mediator of the vascular response to injury.

Christy M Guth, Weifung Luo, Olukemi Jolayemi, Kalyan S Chadalavada, Padmini Komalavilas, Joyce Cheung-Flynn, Colleen M Brophy

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of surgical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A cell permeant phosphopeptide mimetic of Niban inhibits p38 MAPK and restores endothelial function after injury.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Christy M GuthDepartment of Surgery, Vanderbilt University, Nashville, Tennessee. Electronic address: christy.m.guth@vanderbilt.edu.
Weifung LuoDepartment of Surgery, Vanderbilt University, Nashville, Tennessee.
Olukemi JolayemiDepartment of Surgery, Vanderbilt University, Nashville, Tennessee.
Kalyan S ChadalavadaDepartment of Surgery, Vanderbilt University, Nashville, Tennessee.
Padmini KomalavilasVA Tennessee Valley Healthcare System, Nashville, Tennessee.
Joyce Cheung-FlynnDepartment of Surgery, Vanderbilt University, Nashville, Tennessee.
Colleen M BrophyDepartment of Surgery, Vanderbilt University, Nashville, Tennessee; VA Tennessee Valley Healthcare System, Nashville, Tennessee.
Vanderbilt University · USVA Tennessee Valley Healthcare System · US

Funding

PREVENTION OF VEIN GRAFT SPASMR01HL070715 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BROPHY, COLLEEN M · 2003 to 2021
$7.2M
Methods To Reduce Vein Harvest InjuryR01HL105731 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CHEUNG-FLYNN, JOYCE · 2012 to 2015
$1.4M
Development of a vasoactive biogelR41HL071309 · NHLBI · AZERX, INC. · PI BROPHY, COLLEEN M · 2002 to 2002
$95k
PRESERVATION OF ENDOTHELIAL DEPENDENT RELAXATIONI01BX002036 · VA · VETERANS HEALTH ADMINISTRATION · PI BROPHY, COLLEEN M · 2013 to 2016
–
BLRD VA I01 BX002036NHLBI NIH HHS R01 HL070715NHLBI NIH HHS R01 HL105731NHLBI NIH HHS R41 HL071309
6 · The paper itself

Abstract

backgroundHuman saphenous veins used for arterial bypass undergo stretch injury at the time of harvest and preimplant preparation. Vascular injury promotes intimal hyperplasia, the leading cause of graft failure, but the molecular events leading to this response are largely unknown. This study investigated adenosine triphosphate (ATP) as a potential molecular mediator in the vascular response to stretch injury, and the downstream effects of the purinergic receptor, P2X7R, and p38 MAPK activation. MATERIALS AND

methodsA subfailure stretch rat aorta model was used to determine the effect of stretch injury on release of ATP and vasomotor responses. Stretch-injured tissues were treated with apyrase, the P2X7R antagonist, A438079, or the p38 MAPK inhibitor, SB203580, and subsequent contractile forces were measured using a muscle bath. An exogenous ATP (eATP) injury model was developed and the experiment repeated. Change in p38 MAPK phosphorylation after stretch and eATP tissue injury was determined using Western blotting. Noninjured tissue was incubated in the p38 MAPK activator, anisomycin, and subsequent contractile function and p38 MAPK phosphorylation were analyzed.

resultsStretch injury was associated with release of ATP. Contractile function was decreased in tissue subjected to subfailure stretch, eATP, and anisomycin. Contractile function was restored by apyrase, P2X7R antagonism, and p38-MAPK inhibition. Stretch, eATP, and anisomycin-injured tissue demonstrated increased phosphorylation of p38 MAPK.

conclusionsTaken together, these data suggest that the vascular response to stretch injury is associated with release of ATP and activation of the P2X7R/P38 MAPK pathway, resulting in contractile dysfunction. Modulation of this pathway in vein grafts after harvest and before implantation may reduce the vascular response to injury.

Indexed as

Adenosine TriphosphateAnimalsAorta, AbdominalBiomarkersBiomechanical PhenomenaBlotting, WesternFemaleMuscle Contractionp38 Mitogen-Activated Protein KinasesRatsRats, Sprague-DawleyReceptors, Purinergic P2X7Stress, MechanicalVascular System InjuriesAdenosine TriphosphateBiomarkersp38 Mitogen-Activated Protein KinasesReceptors, Purinergic P2X7ATPP2X7Rp38 MAPKSubfailure stretchVascular injury

Identifiers

PMID28807217
PMCPMC5962343
OpenAlexW2600762091

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.